GeneNovate Investors’ Day 2025 – Startup Pitches | National Strategy Gene- and Cell-based Therapies | Deadline: December 16, 2024 | Berlin

What: GeneNovate Investors’ Day 2025 – Startup Pitches l National Strategy Gene- and Cell-based Therapies

When: June 27, 2025 | DEADLINE: December 16, 2024

Where: Akademie der Künste, Pariser Platz 4, 10117 Berlin

Who: Early career researchers (e.g. PhD/PostDocs) with translational academic projects (pre-seed phase) and early-stage startups

Info: Are you part of a start-up or late-stage academic project in the field of gene- and cell-based innovations? Then apply for GeneNovate’s Investors’ Day, where you will receive pitch training, connect with key investors and industry leaders and debut your pitch in front of an expert committee of academic representatives, public and private investors. Start your application today!

Registration:https://www.bihealth.org/en/translation/nationales-netzwerkbuero-fuer-gen-und-zelltherapien/genenovate-investors-day